BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30906375)

  • 1. Hypertension and Neuropsychiatric Symptoms in Patients with Drug-Naïve Alzheimer's Disease.
    Hwang I; Baek KH; Han JH; Ha SW; Yang Y
    Dement Neurocogn Disord; 2017 Sep; 16(3):78-82. PubMed ID: 30906375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.
    Kaufer DI; Cummings JL; Christine D; Bray T; Castellon S; Masterman D; MacMillan A; Ketchel P; DeKosky ST
    J Am Geriatr Soc; 1998 Feb; 46(2):210-5. PubMed ID: 9475452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
    Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the Neuropsychiatric Inventory Questionnaire (NPI-Q) in the assessment of a sample of patients with Alzheimer's disease in Chile.
    Musa G; Henríquez F; Muñoz-Neira C; Delgado C; Lillo P; Slachevsky A
    Dement Neuropsychol; 2017; 11(2):129-136. PubMed ID: 29213504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.
    Steinberg M; Hess K; Corcoran C; Mielke MM; Norton M; Breitner J; Green R; Leoutsakos J; Welsh-Bohmer K; Lyketsos C; Tschanz J
    Int J Geriatr Psychiatry; 2014 Feb; 29(2):153-9. PubMed ID: 23681754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden.
    Iravani B; Abdollahi E; Eslamdoust-Siahestalkhi F; Soleimani R
    Front Neurol; 2022; 13():877143. PubMed ID: 35968317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reporting of neuropsychiatric symptoms in electronic health records of individuals with Alzheimer's disease: a natural language processing study.
    Eikelboom WS; Singleton EH; van den Berg E; de Boer C; Coesmans M; Goudzwaard JA; Vijverberg EGB; Pan M; Gouw C; Mol MO; Gillissen F; Fieldhouse JLP; Pijnenburg YAL; van der Flier WM; van Swieten JC; Ossenkoppele R; Kors JA; Papma JM
    Alzheimers Res Ther; 2023 May; 15(1):94. PubMed ID: 37173801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and psychological symptoms of dementia in patients with Alzheimer's disease and family caregiver burden: a path analysis.
    Kim B; Noh GO; Kim K
    BMC Geriatr; 2021 Mar; 21(1):160. PubMed ID: 33663416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.
    Rosenberg PB; Lanctôt KL; Herrmann N; Mintzer JE; Porsteinsson AP; Sun X; Raman R
    J Alzheimers Dis; 2016 Aug; 54(1):373-81. PubMed ID: 27567808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of caregiver demographic variables with neuropsychiatric symptoms in Alzheimer's disease patients for distress on the Neuropsychiatric Inventory (NPI).
    Godinho C; Camozzato A; Kochhann R; Chaves MLF
    Dement Neuropsychol; 2008; 2(3):211-216. PubMed ID: 29213573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study.
    Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating traits and states identifies the importance of chronic neuropsychiatric symptoms for cognitive prognosis in mild dementia.
    Giil LM; Aarsland D; Vik-Mo AO
    Alzheimers Dement (Amst); 2021; 13(1):e12152. PubMed ID: 33665342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
    Nagata T; Shinagawa S; Nakajima S; Plitman E; Mihashi Y; Hayashi S; Mimura M; Nakayama K
    J Alzheimers Dis; 2016; 50(3):839-45. PubMed ID: 26836181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.
    Vik-Mo AO; Giil LM; Ballard C; Aarsland D
    Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Icelandic version of the Neuropsychiatric Inventory with Caregiver Distress (NPI-D).
    Davidsdottir SR; Snaedal J; Karlsdottir G; Atladottir I; Hannesdottir K
    Nord J Psychiatry; 2012 Feb; 66(1):26-32. PubMed ID: 21770826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
    Ng KP; Pascoal TA; Mathotaarachchi S; Chan YH; Jiang L; Therriault J; Benedet AL; Shin M; Kandiah N; Greenwood CMT; Rosa-Neto P; Gauthier S;
    Transl Neurodegener; 2021 Jan; 10(1):1. PubMed ID: 33390174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.